Newborn screening testing services for bdaach, korea - task order for option IV. POP is 29 september 2023 through 28 september 2024.
Ended Awarded Last action
- Contract number
- W81K0223F0093
- Awardee
-
Revvity Omics Inc. UEI LDJULX8K6M85 Part of Revvity Inc.
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Obligated
- $44,717
Award facts
- Opportunity
-
- W81K0219Q0218 Solicitation number
- Contract value 100% obligated
- $44,716.56 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 621511 Medical Laboratories
- PSC
- Q301 Reference Laboratory Testing
- Set-aside
- No set-aside
- Competition
- Competed under SAP Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- South Korea
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Original award | $44,717 |
About this award
This federal contract award is for newborn screening testing services provided by Revvity Omics Inc., doing business as Perkinelmer Genetics, to the Defense Health Agency (DHA) for the Brian D. Allgood Army Community Hospital (BDAACH) in South Korea. The contract is a firm fixed price delivery order under a larger indefinite delivery, indefinite quantity (IDIQ) contract awarded to Perkinelmer Genetics in 2019 by the DHA to provide newborn screening for Army medical facilities in Korea. The current task order, with a ceiling value of $44,716.56, will cover the period from September 29, 2023 through September 28, 2024. Perkinelmer Genetics, a subsidiary of the parent company Revvity Inc., specializes in medical imaging and genetic testing services, and has significant experience providing newborn screening programs to support the military healthcare system.
Quick answers
Who was awarded contract W81K0223F0093?
W81K0223F0093 was awarded to Revvity Omics Inc. by Medical Command (Department of the Army) on September 29, 2023.
How much is contract W81K0223F0093 worth?
The government has obligated $44,717 on W81K0223F0093.
Which agency awarded contract W81K0223F0093?
Medical Command (Department of the Army) awarded W81K0223F0093, with funding from Defense Health Agency (Department of Defense).
Is contract W81K0223F0093 an order under another contract?
Yes. W81K0223F0093 is a delivery order under W81K0219D0011, an indefinite delivery contract.
Was contract W81K0223F0093 competed?
The extent of competition for W81K0223F0093 was competed under sap.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award